Home
This site is intended for healthcare professionals

MASH Academy: Diagnostic Updates in Metabolic Dysfunction-Associated Steatohepatitis

11th Jul 2024
11:30pm - 1:00am (GMT)
11th - 12th Jul 2024
11:30pm - 1:00am (GMT)
Hosted on MedAll
Attendance certificate available
This event has ended. Similar events
Free
ONLINE

Catch-up content

2

Description

This program is funded by an independent grant from Novo Nordisk. This online education program has been designed solely for healthcare professionals in the USA. The content is not available for healthcare professionals in any other country.

Join our global experts for this accredited CME six part MASH Academy with address from the American Liver Foundation. This session is presented by Professor Arun Sanyal, analysing the latest clinical insights in MASH diagnosis. Hone your skills in developing personalized treatment plans for a diverse range of patients and settings, while integrating a multidisciplinary approach.

In this upcoming teaching session, Professor Sanyal will delve into the latest diagnostic criteria and guidelines for Metabolic Associated SteatoHepatitis (MASH). The course will equip participants with skills to critically analyze patient symptoms and risk factors specific to MASH, emphasizing the importance of considering demographic and lifestyle variables in the evaluation process. Attendees will also gain skills in precisely interpreting results from non-invasive tests and biomarkers, with an emphasis on their specificity and sensitivity.This comprehensive analysis aims to enhance participants' diagnostic acumen, enabling more precise and effective management of MASH in diverse patient populations.

Presented by Professor Arun Sanyal

Professor Arun Sanyal, M.D., is a distinguished Professor of Medicine, Physiology, and Molecular Pathology at Virginia Commonwealth University, with over 25 years of expertise in hepatology. He leads the NIH NASH Clinical Research Network, the NIMBLE consortium, and the Liver Forum, focusing on liver diseases like NAFLD and NASH, and their complications. Dr. Sanyal has made significant contributions to the field, authoring over 350 research articles in top medical journals and shaping national practice guidelines. His leadership roles include serving as president of the American Association for the Study of Liver Diseases and on numerous advisory boards. A recipient of multiple prestigious awards, Dr. Sanyal continues to impact global liver disease management and research, supported by continuous NIH funding since 1995.

Who is this course for

This online education program has been designed solely for healthcare professionals in the USA. The course provides continuing education for:

✅ Gastroenterologists

✅ Hepatologists

✅ Primary Care Physicians

✅ Endocrinologists

✅ Cardiologists

✅ Nurse Practitioners

✅ Physician Assistants

✅ Dietitians/Nutritionists

✅ Pharmacists

✅ Other Health Professionals

Continuing Education Information

This continuing education activity is provided by AffinityCE and MedAll. This activity provides continuing education credit for physicians, physician assistants, nurses, and nurse practitioners and pharmacists. A statement of participation is available to other attendees.

Learning Objectives

At the completion of this activity, participants should be able to:

  • Evaluate the latest diagnostic criteria and guidelines for MASH.
  • Analyze patient symptoms and risk factors specific to MASH, incorporating demographic and lifestyle variables.
  • Interpret results from non-invasive tests and biomarkers, considering their specificity and sensitivity in MASH diagnosis.

Faculty

Arun J. Sanyal, M.D.

Professor, Director of Stravitz-Sanyal Institute for Liver Disease and Metabolic Health, School of Medicine - Internal Medicine - Virginia Commonwealth University

Tony Villiotti

Patient Advocate

Faculty Disclosures

Arun J. Sanyal

Consultant: Eli Lilly and Company, Echosens, Abbott, Promed, Genfit, Satellite Bio, Corcept, Arrowhead, Boston Pharmaceuticals, Variant, Cascade, 89Bio, AstraZeneca, Alnylam, Regeneron, Boehringer Ingelheim, Bristol-Myers Squibb, Genentech, Gilead, Histoindex, Janssen, Lipocine, Madrigal, Merck, Glaxo-Smith Kline, Novartis, Akero, Novo Nordisk, Path AI, Histoindex, Pfizer, Poxel, Salix, Myovant, Median technologies, Sequana, Surrozen, Takeda, Terns, and Zydus.

Institution has received grant support from AstraZeneca, Bristol-Myers Squibb, Gilead, Intercept, Mallinckrodt, Merck, Ocelot, Novartis, and Salix.

Royalties from Elsevier and UpToDate. He has stock options in Duret, Genfit, Tizsiana, Inversago.

No unapproved product related discussions to disclose.

Tony Villiotti

Consultant: Madrigal Pharmaceuticals & Regeneron.

No unapproved product related discussions to disclose.

Disclosures

AffinityCE staff, MedAll staff, as well as planners and reviewers, have no relevant financial relationships with ineligible companies to disclose.

Mitigation of Relevant Financial Relationships

AffinityCE adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible companies. Relevant financial relationships were mitigated by the peer review of content by non-conflicted reviewers prior to the commencement of the program.

Activity Accreditation for Health Professions

Physicians

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and Medall. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.

AffinityCE designates this live activity for a maximum of 1.5 _AMA PRA Category 1 Credits_™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and MedAll AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.

AffinityCE designates this live activity for a maximum of 1.5 _AMA PRA Category 1 Credits_™. Physician assistants should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Practitioners

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and MedAll. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.

AffinityCE designates this live activity for a maximum of 1.5 _AMA PRA Category 1 Credits_™. Nurse practitioners should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

Continuing Nursing Education is provided for this program through the joint providership between MedAll and AffinityCE. AffinityCE is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC). This live activity provides a maximum of 1.5 hours of continuing nursing education credit.

Criteria for Claiming CNE Credit: Participants must have registered and attended the entire program. Attendance is monitored online for participation in the entire activity.

Pharmacists

AffinityCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education (CPE).

UAN: 0829-9999-24-156-L01-P

Activity Type: Knowledge-based

CEUs: 1.5

No cost to participate.

Participant CE records will be electronically communicated to CPE Monitor.

Pharmacist Learning Objectives

At the conclusion of this web conference, participants should be able to:

  • Evaluate the latest diagnostic criteria and guidelines for MASH.
  • Analyze patient symptoms and risk factors specific to MASH, incorporating demographic and lifestyle variables.
  • Accurately interpret results from non-invasive tests and biomarkers, considering their specificity and sensitivity in MASH diagnosis.

Criteria for Claiming CPE Credit: Participants must have registered and attended the entire program. Attendance is monitored online for participation in the entire activity.

System Requirements

Mobile device (e.g., large-format smart phone; laptop or tablet computer) or desktop computer with a video display of at least 1024 × 768 pixels at 24-bit color depth, capable of connecting to the Internet at broadband or faster speeds, with a current version Internet browser and popular document viewing software (e.g., Microsoft Office, PDF viewer, image viewer) installed. Support for streaming or downloadable audio-visual materials (e.g., streaming MP4, MP3 audio) in hardware and software may be required to view, review, or participate in portions of the program

Other Professionals

All other health care professionals completing this continuing education activity will be issued a statement of participation indicating the number of hours of continuing education credit. This may be used for professional education CE credit. Please consult your accrediting organization or licensing board for their acceptance of this CE activity.

Participation Costs

There is no cost to participate in this program.

CME Inquiries

For all CME policy-related inquiries, please contact us at ce@affinityced.com.

How to Earn CE Credit

How to Earn CE Credit: Pharmacists Only

Diagnostic Updates in Metabolic Dysfunction-Associated Steatohepatitis

Registration for the Activity does not establish an account in the CE Center or automatically provide continuing education credit. You must sign into the CE Center site and evaluate the content of the activity to earn CE credit.

1.Please use the private evaluation link provided to you to access the CE Center.

IMPORTANT: You must use this link every time you access the CE Center for this activity.

2. Select the activity: Diagnostic Updates in Metabolic Dysfunction-Associated Steatohepatitis

3. Enter an e-mail address and password to begin setting up your profile. Select “I Forgot My Password” if you need to reset the password you set up.

4. Verify, correct, or add your information.

5. Participants claiming Pharmacist CE credits will need to supply their Date of birth and NABP e-Profile ID. Pharmacy CE records will be electronically communicated to CPE Monitor.

6. Complete the post-activity evaluation after attending the entire program.

7. After completing the activity evaluation, you will be able to download your CE certificate. Your CE record will also be stored here for later retrieval.

8. The website is open for completing your evaluation until July 24, 2024.

9. After the website has closed, you can come back to the site at any time to download your certificate, but you will not be able to add any evaluations.Please send any customer service requests to cds_support+medall@affinityced.com.

Learning objectives

At the end of this session attendees will be able to:

  1. Evaluate the latest diagnostic criteria and guidelines for MASH.
  2. Analyze patient symptoms and risk factors specific to MASH, incorporating demographic and lifestyle variables.
  3. Accurately interpret results from non-invasive tests and biomarkers, considering their specificity and sensitivity in MASH diagnosis.
View all

Similar events and on demand videos

 
11th - 12th Jul 2024
11:30pm - 1:00am (GMT)
Hosted on MedAll
Attendance certificate available
This event has ended. Similar events
Free
ONLINE